Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

NCT06279793 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Intensive Care Unit
Coronary Artery Bypass Grafting (CABG)
High Risk Patients
Cardiopulmonary Bypass
Elective Cardiac Surgery
Valvular Heart Surgery
Multiple Valve Surgeries
Combined Cardiac Procedures
Aortic Surgical Procedures
Adult Patients ≥ 18 Years
Combined Valve and CABG
Combined Cardiac and Aortic Surgical Procedures

Interventions

DRUG: Fish Oil
DRUG: Intravenous 0.9% Sodium Chloride

Sponsor

GCP-Service International West GmbH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]